GlassScriptPhysician profile
Kacie Dunn
NPI 1073121406
$1,283.41
in general payments reported to CMS, 2019-2025
19 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $289 · 2023: $465 · 2024: $156 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.07 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $200.03 | 2022-2023 | Adept |
| Abbvie INC. | $152.60 | 2021-2023 | |
| Exeltis, USA INC. | $143.40 | 2021-2024 | Slynd |
| Sumitomo Pharma America, INC. | $115.20 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $113.90 | 2021 | |
| Millicent US INC | $104.79 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Organon LLC | $65.06 | 2022-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $62.41 | 2021-2025 | |
| Pfizer INC. | $58.46 | 2024-2025 | |
| Coopersurgical, INC. | $49.49 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Myovant Sciences INC. | $43.56 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $42.61 | 2024-2025 | |
| Scynexis, INC. | $27.40 | 2022 | |
| Astellas Pharma US INC | $25.12 | 2023 | Veozah |
| Evofem Biosciences, INC. | $19.24 | 2025 | Phexxi, Solosec, Phexx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $18.28 | 2023 | Ova1 |
| Hologic Sales and Service, LLC | $16.27 | 2023 | Acessa Provu System, Myosure Tissue Removal Device |
| Avion Pharmaceuticals | $13.22 | 2021 | |
| Agile Therapeutics, INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kacie Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.